Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 6 911 JPY 2.84% Market Closed
Market Cap: 547.7B JPY
Have any thoughts about
Cosmos Pharmaceutical Corp?
Write Note

Intrinsic Value

The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 6 933.86 JPY. Compared to the current market price of 6 911 JPY, Cosmos Pharmaceutical Corp is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6 933.86 JPY
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cosmos Pharmaceutical Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Cosmos Pharmaceutical Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Cosmos Pharmaceutical Corp?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Cosmos Pharmaceutical Corp

Provide an overview of the primary business activities
of Cosmos Pharmaceutical Corp.

What unique competitive advantages
does Cosmos Pharmaceutical Corp hold over its rivals?

What risks and challenges
does Cosmos Pharmaceutical Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cosmos Pharmaceutical Corp.

Provide P/S
for Cosmos Pharmaceutical Corp.

Provide P/E
for Cosmos Pharmaceutical Corp.

Provide P/OCF
for Cosmos Pharmaceutical Corp.

Provide P/FCFE
for Cosmos Pharmaceutical Corp.

Provide P/B
for Cosmos Pharmaceutical Corp.

Provide EV/S
for Cosmos Pharmaceutical Corp.

Provide EV/GP
for Cosmos Pharmaceutical Corp.

Provide EV/EBITDA
for Cosmos Pharmaceutical Corp.

Provide EV/EBIT
for Cosmos Pharmaceutical Corp.

Provide EV/OCF
for Cosmos Pharmaceutical Corp.

Provide EV/FCFF
for Cosmos Pharmaceutical Corp.

Provide EV/IC
for Cosmos Pharmaceutical Corp.

Show me price targets
for Cosmos Pharmaceutical Corp made by professional analysts.

What are the Revenue projections
for Cosmos Pharmaceutical Corp?

How accurate were the past Revenue estimates
for Cosmos Pharmaceutical Corp?

What are the Net Income projections
for Cosmos Pharmaceutical Corp?

How accurate were the past Net Income estimates
for Cosmos Pharmaceutical Corp?

What are the EPS projections
for Cosmos Pharmaceutical Corp?

How accurate were the past EPS estimates
for Cosmos Pharmaceutical Corp?

What are the EBIT projections
for Cosmos Pharmaceutical Corp?

How accurate were the past EBIT estimates
for Cosmos Pharmaceutical Corp?

Compare the revenue forecasts
for Cosmos Pharmaceutical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cosmos Pharmaceutical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cosmos Pharmaceutical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cosmos Pharmaceutical Corp compared to its peers.

Compare the P/E ratios
of Cosmos Pharmaceutical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Cosmos Pharmaceutical Corp with its peers.

Analyze the financial leverage
of Cosmos Pharmaceutical Corp compared to its main competitors.

Show all profitability ratios
for Cosmos Pharmaceutical Corp.

Provide ROE
for Cosmos Pharmaceutical Corp.

Provide ROA
for Cosmos Pharmaceutical Corp.

Provide ROIC
for Cosmos Pharmaceutical Corp.

Provide ROCE
for Cosmos Pharmaceutical Corp.

Provide Gross Margin
for Cosmos Pharmaceutical Corp.

Provide Operating Margin
for Cosmos Pharmaceutical Corp.

Provide Net Margin
for Cosmos Pharmaceutical Corp.

Provide FCF Margin
for Cosmos Pharmaceutical Corp.

Show all solvency ratios
for Cosmos Pharmaceutical Corp.

Provide D/E Ratio
for Cosmos Pharmaceutical Corp.

Provide D/A Ratio
for Cosmos Pharmaceutical Corp.

Provide Interest Coverage Ratio
for Cosmos Pharmaceutical Corp.

Provide Altman Z-Score Ratio
for Cosmos Pharmaceutical Corp.

Provide Quick Ratio
for Cosmos Pharmaceutical Corp.

Provide Current Ratio
for Cosmos Pharmaceutical Corp.

Provide Cash Ratio
for Cosmos Pharmaceutical Corp.

What is the historical Revenue growth
over the last 5 years for Cosmos Pharmaceutical Corp?

What is the historical Net Income growth
over the last 5 years for Cosmos Pharmaceutical Corp?

What is the current Free Cash Flow
of Cosmos Pharmaceutical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cosmos Pharmaceutical Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cosmos Pharmaceutical Corp

Current Assets 156.4B
Cash & Short-Term Investments 51.4B
Receivables 658m
Other Current Assets 104.3B
Non-Current Assets 328.6B
PP&E 302.2B
Intangibles 474m
Other Non-Current Assets 25.9B
Current Liabilities 216.8B
Accounts Payable 181.7B
Other Current Liabilities 35.2B
Non-Current Liabilities 31B
Long-Term Debt 22.3B
Other Non-Current Liabilities 8.7B
Efficiency

Earnings Waterfall
Cosmos Pharmaceutical Corp

Revenue
985.2B JPY
Cost of Revenue
-789.3B JPY
Gross Profit
195.9B JPY
Operating Expenses
-161.8B JPY
Operating Income
34.1B JPY
Other Expenses
-8B JPY
Net Income
26.1B JPY

Free Cash Flow Analysis
Cosmos Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
50/100
Profitability
Score

Cosmos Pharmaceutical Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Cosmos Pharmaceutical Corp's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

78/100
Solvency
Score

Cosmos Pharmaceutical Corp's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Cosmos Pharmaceutical Corp

Wall Street analysts forecast Cosmos Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Cosmos Pharmaceutical Corp is 8 648.03 JPY with a low forecast of 6 716.5 JPY and a high forecast of 10 500 JPY.

Lowest
Price Target
6 716.5 JPY
3% Downside
Average
Price Target
8 648.03 JPY
25% Upside
Highest
Price Target
10 500 JPY
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Cosmos Pharmaceutical Corp?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Cosmos Pharmaceutical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp

Country

Japan

Industry

Retail

Market Cap

547.7B JPY

Dividend Yield

1.3%

Description

COSMOS Pharmaceutical Corp. engages in the operation of drugstores. The company is headquartered in Fukuoka, Fukuoka-Ken and currently employs 4,872 full-time employees. The company went IPO on 2004-11-11. The firm offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. The company also provides tobacco and others.

Contact

FUKUOKA-KEN
Fukuoka
4F, S Kan, Daiichi Fukuoka Bldg., 2-10-1, Hakataeki Higashi, Hakata-ku
+81924330660.0
www.cosmospc.co.jp

IPO

2004-11-11

Employees

4 872

Officers

President & Representative Director
Mr. Hideaki Yokoyama
GM of Corporate Planning Department & Director
Mr. Futoshi Shibata

See Also

Discover More
What is the Intrinsic Value of one Cosmos Pharmaceutical Corp stock?

The intrinsic value of one Cosmos Pharmaceutical Corp stock under the Base Case scenario is 6 933.86 JPY.

Is Cosmos Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 6 911 JPY, Cosmos Pharmaceutical Corp is Fairly Valued.

Back to Top